Literature DB >> 28972878

Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.

Lingbo Kong1, Yu Lu1, Siyu Zhang1, Yuemin Nan1, Liang Qiao2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The nutrients play important roles in the development and progression of NAFLD. High-calorie diet, especially the diet rich in saturated fatty acids and cholesterol, as well as sugary drinks with high fructose content, induces hepatic steatosis and triggers progression of steatohepatitis, fibrosis, and even hepatocellular carcinoma. Disordered micronutrient status and gut microbiota are also involved in the pathogenesis of NAFLD. Nutrients related NAFLD could be aggravated by a genetic predisposition, for instance, genetic mutations in patatinlike phospholipase domain-containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2). Reduction of caloric intake through lifestyle interventions and use of dietary supplements such as omega-3 fatty acids, vitamins, and probiotics may help alleviate liver injury in NAFLD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28972878

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  7 in total

1.  Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease.

Authors:  Farnush Bakhshimoghaddam; Mohammad Alizadeh
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 2.  Heterogeneity in Metabolic Responses to Dietary Fructose.

Authors:  Ruixue Hou; Chinmayee Panda; V Saroja Voruganti
Journal:  Front Genet       Date:  2019-10-31       Impact factor: 4.599

Review 3.  Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis.

Authors:  Yujing Fan; Yunpeng Li; Yanjie Chu; Jing Liu; Lin Cui; Dekai Zhang
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

4.  Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population.

Authors:  Xiaoyan Hao; Cong Ma; Tianyuan Xiang; Lei Ou; Qiang Zeng
Journal:  Front Genet       Date:  2021-02-18       Impact factor: 4.599

5.  The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease.

Authors:  Xiaoyan Hao; Qiang Zeng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-22       Impact factor: 3.168

Review 6.  The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review.

Authors:  Thomas Pixner; Nathalie Stummer; Anna Maria Schneider; Andreas Lukas; Karin Gramlinger; Valérie Julian; David Thivel; Katharina Mörwald; Katharina Maruszczak; Harald Mangge; Julian Gomahr; Daniel Weghuber; Dieter Furthner
Journal:  Life (Basel)       Date:  2022-06-05

Review 7.  Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

Authors:  Tingyu Fang; Hua Wang; Xiaoyue Pan; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Int J Biol Sci       Date:  2022-09-06       Impact factor: 10.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.